About EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

At the moment the company generates 3M USD in revenues.

On its last earning announcement, the company reported a loss of -2.17$ per share.

The book value per share is 1.14$

EyeGate Pharmaceuticals, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3M - -7M -259.89% -7M -2.17 - - 3M 1.14 -8M - -8M